Cardiology and Cardiovascular Medicine

Coronary atherosclerosis and sudden cardiac death in the young: another face of the culprit, another way of striking?

Coronary artery atherosclerosis is a major cause of sudden cardiac
death (SCD) in the young, accoun ting for nearly 25% of fatalitie s in
this age group (≤40 years old) [1]. Interestingl y, the composition of
the culprit atherosclerotic plaque in young subjects often shows a pecu-
liar morphology, consisting predominantly of smooth muscle cells
(SMCs) with a variable amount of extracellular matrix, and minimal
or absent lipid core [2] leading to the definition of “non-atheromatous

Digoxin and platelet activation in patients with atrial fibrillation: In vivo and in vitro study

Background-Digoxin use was shown to be associated with an increased risk of cardiovascular events in atrial fibrillation (AF). We hypothesized that digoxin may affect cardiovascular risk by increasing platelet activation. Methods and Results-Post hoc analysis of a prospective study of anticoagulated patients with AF. Patients were divided into 2 groups balanced for age, sex, and cardiovascular risk factors: digoxin users (n=132) and nonusers (n=388). Urinary excretion of 11‐dehydro‐thromboxane B2 (TxB2), a marker of platelet activation, and serum digoxin concentration (SDC) were measured.

Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events

Background and aims: Antioxidant status has been shown to be associated with cardiovascular events (CVEs). The aim of the study was to develop an assay measuring serum hydrogen peroxide (H2O2) break-down activity (HBA) of healthy subjects (HS) and to validate it in a cohort of patients with atrial fibrillation (AF). Methods: We developed the HBA assay in 121 HS and validated it in 842 AF patients. The occurrence of CVEs was registered and correlated with HBA in AF during a median follow-up of 30.6 months (3226 patient-years).

Ecografo GE Vivid-E9

Italiano

The GE Vivid E9 is the top-of-the-line premium cardiovascular ultrasound machine from GE. It has amazing image quality and the latest features including xMatrix and 4D cardiac. This makes cardiac evaluation more efficient, especially in stress echo exams. The E9 also includes Accelerated Volume Architecture, resulting in faster processing times and more patient data via increased volume size, resolution, and rate.

Results of infrageniculate bypasses using the profunda femoris artery as inflow source

BACKGROUND:
When the common femoral artery is not accessible for infrainguinal bypass grafting, the profunda femoris artery (PFA) can be a valuable alternative inflow source for distal arterial revascularization. The purpose of this retrospective study was to evaluate the results of infrageniculate bypass grafting via the PFA as inflow source for critical limb ischemia.
METHODS:

Natriuretic peptides in heart failure: Current achievements and future perspectives

The last two centuries have witnessed countless discoveries in the field of medicine that found their roots in the up growing development of technology as well as in the visionary ideas of brilliant scientists and research groups. One of the most important discoveries in the field of cardiovascular medicine allowed to break the paradigm identifying the heart with mere mechanical pump and to characterize its intriguing endocrine properties.

Hypertension, acute stent thrombosis, and paraplegia 6 months after thoracic endovascular aortic repair for blunt thoracic aortic injury in a 22-year-old patient

Thoracic endovascular aortic repair (TEVAR) is a less invasive option for managing traumatic injuries of the descending aorta in polytraumatized patients. Concerns arise when treating young patients with TEVAR. A 22-year-old male was admitted to the emergency department following a high-impact road traffic collision. Whole-body computed tomography (CT) scan documented multiple injuries, including rupture of descending thoracic aorta just below the isthmus. There was no evidence of paraplegia or stroke.

multimodal treatment for post-pneumonectomy bronchopleural fistula associated with empyema

Post-pneumonectomy bronchopleural fistula associated with empyema still remains a dreaded complication in thoracic surgery. A variety of surgical and endoscopic procedures have been proposed over the years, but none of these has been suitable for all patients. Herein, we report a new multimodal approach, including the insertion of tracheobronchial conical stent, the open pleural packing, and the closure of bronchial stump with omentoplasty. This procedure was successfully applied in 11 patients with post-pneumonectomy bronchopleural fistula with empyema.

Temporary treatment of complex subglottic stenosis by an on-site customized stent

Sub-glottic stenosis may be complex in shape, making challenging its treatment with standard commercially available stents. Personalized stents can lead to successful treatment; however they are not readily available due to the customization waiting time. We report the use of on-site customized temporary silicone stents for difficult benign sub-glottic stenosis in five patients unfit for surgery.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma